Dr Michael Buschle

Michael Buschle

Investment Professional - Advisor to HBM Partners

More than 25 years experience in biotech and pharma. PhD from the University of London. Research at St. Jude’s Childrens Research Hospital, Boehringer Ingelheim-owned Institute of Molecular Pathology, Vienna. Industrial experience: Boehringer Ingelheim, Co-founder of Intercell with successful IPO, Chief Scientific Officer of Glenmark Pharmaceuticals.


© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171